Switch from enfuvirtide to raltegravir lowers plasma concentrations of darunavir and tipranavir: a pharmacokinetic substudy of the EASIER-ANRS 138 trial.
about
Efficacy and safety of raltegravir in treatment-experienced HIV-1-infected patients switching from enfuvirtide-based regimens: 48 week results of the randomized EASIER ANRS 138 trial.Incidence and risk factors for liver enzymes elevations in highly treatment-experienced patients switching from enfuvirtide to raltegravir: a sub-study of the ANRS-138 EASIER trial.Role of raltegravir in HIV-1 management.Pharmacology of HIV integrase inhibitors.
P2860
Switch from enfuvirtide to raltegravir lowers plasma concentrations of darunavir and tipranavir: a pharmacokinetic substudy of the EASIER-ANRS 138 trial.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Switch from enfuvirtide to ral ...... of the EASIER-ANRS 138 trial.
@ast
Switch from enfuvirtide to ral ...... of the EASIER-ANRS 138 trial.
@en
type
label
Switch from enfuvirtide to ral ...... of the EASIER-ANRS 138 trial.
@ast
Switch from enfuvirtide to ral ...... of the EASIER-ANRS 138 trial.
@en
prefLabel
Switch from enfuvirtide to ral ...... of the EASIER-ANRS 138 trial.
@ast
Switch from enfuvirtide to ral ...... of the EASIER-ANRS 138 trial.
@en
P2093
P2860
P356
P1476
Switch from enfuvirtide to ral ...... of the EASIER-ANRS 138 trial.
@en
P2093
Anne-Marie Taburet
Aurélie Barrail-Tran
Constance Delaugerre
François Raffi
Isabelle Charreau
Jean-Michel Molina
Jean-Pierre Aboulker
Joséphine Braun
Lauriane Goldwirt
Nathalie de Castro
P2860
P304
P356
10.1128/AAC.01827-10
P407
P577
2011-05-16T00:00:00Z